Muslum Akgoz, Seda Damla Hatipoglu, Gulacti Topcu, Ahmet Ceyhan Goren, Turan Oztur, Burhanettin Yalcinkaya: Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species. In: Phytochemical Analysis. 2017, S.541–549, doi:10.1002/pca.2703.
A Ortega, JF Blount, PS Manchand: Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae). In: J. Chem. Soc., Perkin Trans. 1. 1982, S.2505–2508, doi:10.1039/P19820002505.
K. A. MacLean, M. W. Johnson, C. J. Reissig, T. E. Prisinzano, R. R. Griffiths: Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. In: Psychopharmacology. Band 226, Nummer 2, März 2013, S. 381–392, doi:10.1007/s00213-012-2912-9, PMID 23135605, PMC 3581702 (freier Volltext).
B.L. Roth et al.: Salvinorin A: A potent naturally occurring nonnitrogenous opioid selective agonist. In: PNAS. Band 99, 2002, S. 11934–11939. PMID 12192085doi:10.1073/pnas.182234399.
Timothy A. Vortherms, Bryan L. Roth: Salvinorin A – From Natural Product to Human Therapeutics. In: Molecular Interventions, 2006, Vol. 6, No. 5, S. 257–265. doi:10.1124/mi.6.5.7.
Lukasz Kutrzeba, Ferreira, Zjawiony: Salvinorins J from Salvia divinorum: Mutarotation in the Neoclerodane System. In: J. Nat. Prod. 72. Jahrgang, Nr.7, 2009, S.1361–1363, doi:10.1021/np900181q.
TA Munro, KK Duncan, W Xu, Y Wang, LY Liu-Chen, WA Carlezon, BM Cohen, C Béguin: Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. In: Bioorganic & Medicinal Chemistry. 16. Jahrgang, Nr.3, Februar 2008, S.1279–86, doi:10.1016/j.bmc.2007.10.067, PMID 17981041, PMC 2568987 (freier Volltext).
nih.gov
ncbi.nlm.nih.gov
K. A. MacLean, M. W. Johnson, C. J. Reissig, T. E. Prisinzano, R. R. Griffiths: Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. In: Psychopharmacology. Band 226, Nummer 2, März 2013, S. 381–392, doi:10.1007/s00213-012-2912-9, PMID 23135605, PMC 3581702 (freier Volltext).
B.L. Roth et al.: Salvinorin A: A potent naturally occurring nonnitrogenous opioid selective agonist. In: PNAS. Band 99, 2002, S. 11934–11939. PMID 12192085doi:10.1073/pnas.182234399.
TA Munro, KK Duncan, W Xu, Y Wang, LY Liu-Chen, WA Carlezon, BM Cohen, C Béguin: Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. In: Bioorganic & Medicinal Chemistry. 16. Jahrgang, Nr.3, Februar 2008, S.1279–86, doi:10.1016/j.bmc.2007.10.067, PMID 17981041, PMC 2568987 (freier Volltext).
